S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Calyxt, Inc. stock logo
CLXT
Calyxt
$13.58
$1.25
$7.77
$31.31M1.98139,308 shs254,600 shs
Evogene Ltd. stock logo
EVGN
Evogene
$0.69
-1.4%
$0.80
$0.45
$1.44
$28.24M1.49173,522 shs62,604 shs
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
$0.80
$0.80
$0.55
$1.55
$145.56M0.36919,497 shs38 shs
CVR Partners, LP stock logo
UAN
CVR Partners
$76.20
-2.0%
$72.82
$60.50
$104.86
$821.90M1.2941,424 shs23,788 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Calyxt, Inc. stock logo
CLXT
Calyxt
0.00%0.00%0.00%0.00%-59.25%
Evogene Ltd. stock logo
EVGN
Evogene
-2.14%-11.65%-15.43%-16.43%+10.48%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
0.00%0.00%0.00%0.00%0.00%
CVR Partners, LP stock logo
UAN
CVR Partners
-2.26%-3.86%+19.45%+14.31%-19.29%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Calyxt, Inc. stock logo
CLXT
Calyxt
N/AN/AN/AN/AN/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
1.3182 of 5 stars
3.53.00.00.01.50.00.6
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
N/AN/AN/AN/AN/AN/AN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
1.1344 of 5 stars
0.02.02.50.03.00.81.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Calyxt, Inc. stock logo
CLXT
Calyxt
N/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
3.00
Buy$3.62427.98% Upside
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
N/AN/AN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Calyxt, Inc. stock logo
CLXT
Calyxt
$160K0.00N/AN/A$0.54 per share0.00
Evogene Ltd. stock logo
EVGN
Evogene
$5.64M5.01N/AN/A$0.70 per share0.98
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
$44.31M3.28N/AN/A$0.17 per share4.69
CVR Partners, LP stock logo
UAN
CVR Partners
$681.48MN/A$23.45 per share3.25$28.66 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Calyxt, Inc. stock logo
CLXT
Calyxt
-$16.89M-$3.49N/AN/AN/A-9,979.64%-259.69%-83.22%N/A
Evogene Ltd. stock logo
EVGN
Evogene
-$23.88M-$0.53N/AN/A-423.39%-76.93%-45.13%5/16/2024 (Estimated)
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
-$16.55M-$0.12N/AN/AN/A-47.07%-70.87%-25.23%N/A
CVR Partners, LP stock logo
UAN
CVR Partners
$172.43M$16.314.67N/A25.30%50.45%16.70%4/29/2024 (Confirmed)

Latest MBII, CLXT, UAN, and EVGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2024N/A
CVR Partners, LP stock logo
UAN
CVR Partners
N/AN/AN/AN/AN/AN/A  
3/7/202412/31/2023
Evogene Ltd. stock logo
EVGN
Evogene
-$0.14-$0.13+$0.01-$0.13$1.73 million$0.58 million    
2/20/2024Q4 2023
CVR Partners, LP stock logo
UAN
CVR Partners
N/A$0.94+$0.94$0.94N/A$141.62 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Calyxt, Inc. stock logo
CLXT
Calyxt
N/AN/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
N/AN/AN/AN/AN/A
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
N/AN/AN/AN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
$6.728.82%N/A41.20%1 Years

Latest MBII, CLXT, UAN, and EVGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2024
CVR Partners, LP stock logo
UAN
CVR Partners
Quarterly$1.689.53%3/1/20243/4/20243/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Calyxt, Inc. stock logo
CLXT
Calyxt
N/A
0.61
0.61
Evogene Ltd. stock logo
EVGN
Evogene
N/A
4.96
4.95
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
0.33
0.79
0.55
CVR Partners, LP stock logo
UAN
CVR Partners
1.81
2.20
1.28

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Calyxt, Inc. stock logo
CLXT
Calyxt
6.77%
Evogene Ltd. stock logo
EVGN
Evogene
10.40%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
68.42%
CVR Partners, LP stock logo
UAN
CVR Partners
43.83%

Insider Ownership

CompanyInsider Ownership
Calyxt, Inc. stock logo
CLXT
Calyxt
2.20%
Evogene Ltd. stock logo
EVGN
Evogene
7.40%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
5.00%
CVR Partners, LP stock logo
UAN
CVR Partners
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Calyxt, Inc. stock logo
CLXT
Calyxt
484.97 million4.87 millionNot Optionable
Evogene Ltd. stock logo
EVGN
Evogene
13741.22 million38.17 millionOptionable
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
153182.38 million173.26 millionNot Optionable
CVR Partners, LP stock logo
UAN
CVR Partners
310N/AN/AOptionable

MBII, CLXT, UAN, and EVGN Headlines

SourceHeadline
CVR Partners to Release First Quarter 2024 Earnings ResultsCVR Partners to Release First Quarter 2024 Earnings Results
globenewswire.com - April 16 at 8:30 AM
CVR Partners (NYSE:UAN) Shares Cross Above 200 Day Moving Average of $73.06CVR Partners (NYSE:UAN) Shares Cross Above 200 Day Moving Average of $73.06
americanbankingnews.com - April 11 at 2:52 AM
rabbittransit expanding in Franklin Countyrabbittransit expanding in Franklin County
msn.com - April 10 at 3:58 PM
CVR Partners: Is This Huge Yield A Buy?CVR Partners: Is This Huge Yield A Buy?
seekingalpha.com - April 10 at 12:27 PM
UAN Nov 2024 80.000 callUAN Nov 2024 80.000 call
finance.yahoo.com - March 21 at 3:25 AM
CVR Partners (NYSE:UAN) Cut to "Hold" at StockNews.comCVR Partners (NYSE:UAN) Cut to "Hold" at StockNews.com
marketbeat.com - March 20 at 11:11 PM
UAN Apr 2024 70.000 putUAN Apr 2024 70.000 put
finance.yahoo.com - March 20 at 5:23 PM
CVR Partners (NYSE:UAN) Sees Large Volume IncreaseCVR Partners (NYSE:UAN) Sees Large Volume Increase
marketbeat.com - March 20 at 12:46 PM
UAN Nov 2024 35.000 putUAN Nov 2024 35.000 put
finance.yahoo.com - March 19 at 7:44 PM
CVR Partners Likely To Be Bought: What Is Its Real Value?CVR Partners Likely To Be Bought: What Is Its Real Value?
seekingalpha.com - March 19 at 12:35 PM
CVR Partners (NYSE:UAN) Shares Gap Up to $63.72CVR Partners (NYSE:UAN) Shares Gap Up to $63.72
marketbeat.com - March 19 at 11:51 AM
UAN Apr 2024 60.000 putUAN Apr 2024 60.000 put
ca.finance.yahoo.com - March 16 at 6:53 AM
UAN Apr 2024 60.000 callUAN Apr 2024 60.000 call
ca.finance.yahoo.com - March 16 at 6:53 AM
Want $2000 In Passive Income? Invest $2000 Into These Five Dividend StocksWant $2000 In Passive Income? Invest $2000 Into These Five Dividend Stocks
247wallst.com - March 10 at 9:19 PM
CVR Partners Provides Update on Availability of 2023 K-1 Tax PackagesCVR Partners Provides Update on Availability of 2023 K-1 Tax Packages
globenewswire.com - March 8 at 9:00 AM
UAN Aug 2024 45.000 putUAN Aug 2024 45.000 put
finance.yahoo.com - March 6 at 4:45 PM
UAN May 2024 45.000 putUAN May 2024 45.000 put
finance.yahoo.com - March 6 at 4:45 PM
UAN Apr 2024 85.000 callUAN Apr 2024 85.000 call
finance.yahoo.com - March 4 at 7:31 AM
UAN Apr 2024 75.000 callUAN Apr 2024 75.000 call
finance.yahoo.com - March 4 at 1:37 AM
CVR Partners goes ex dividend tomorrowCVR Partners goes ex dividend tomorrow
msn.com - February 29 at 3:49 PM
CVR Partners: Looking For A Higher Distribution In Q1CVR Partners: Looking For A Higher Distribution In Q1
seekingalpha.com - February 23 at 1:20 PM
CVR Partners, LP (NYSE:UAN) Q4 2023 Earnings Call TranscriptCVR Partners, LP (NYSE:UAN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 22 at 2:12 PM
Want $3000 In Passive Income? Invest $1250 Into These 12 Dividend StocksWant $3000 In Passive Income? Invest $1250 Into These 12 Dividend Stocks
msn.com - February 22 at 9:12 AM
Q4 2023 CVR Partners LP Earnings CallQ4 2023 CVR Partners LP Earnings Call
finance.yahoo.com - February 22 at 9:12 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Calyxt logo

Calyxt

NASDAQ:CLXT
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.
Evogene logo

Evogene

NASDAQ:EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Marrone Bio Innovations logo

Marrone Bio Innovations

NASDAQ:MBII
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.
CVR Partners logo

CVR Partners

NYSE:UAN
CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP is a subsidiary of CVR Energy, Inc.